Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43.4M
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
18.8M
-
Shares change
-
-514K
-
Total reported value, excl. options
-
$230M
-
Value change
-
-$6.45M
-
Put/Call ratio
-
4.24
-
Number of buys
-
34
-
Number of sells
-
-46
-
Price
-
$12.20
Significant Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q1 2021
106 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q1 2021.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.8M shares
of 43.4M outstanding shares and own 43.35% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (2.7M shares), Corriente Advisors, LLC (2.55M shares), BlackRock Inc. (2.25M shares), VANGUARD GROUP INC (1.55M shares), Slate Path Capital LP (1.48M shares), STATE STREET CORP (1.37M shares), GOLDMAN SACHS GROUP INC (602K shares), Prosight Management, LP (557K shares), GEODE CAPITAL MANAGEMENT, LLC (486K shares), and Robertson Stephens Wealth Management, LLC (479K shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.